<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1995-02-01" modified="2020-10-07" version="211">
<accession>P41212</accession>
<accession>A3QVP6</accession>
<accession>A8K076</accession>
<accession>Q9UMF6</accession>
<accession>Q9UMF7</accession>
<accession>Q9UMG0</accession>
<name>ETV6_HUMAN</name>
<protein>
<recommendedName>
<fullName>Transcription factor ETV6</fullName>
</recommendedName>
<alternativeName>
<fullName>ETS translocation variant 6</fullName>
</alternativeName>
<alternativeName>
<fullName>ETS-related protein Tel1</fullName>
<shortName>Tel</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">ETV6</name>
<name type="synonym">TEL</name>
<name type="synonym">TEL1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1994" name="Cell" volume="77" first="307" last="316">
<title>Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation.</title>
<authorList>
<person name="Golub T.R."/>
<person name="Barker G.F."/>
<person name="Lovett M."/>
<person name="Gilliland D.G."/>
</authorList>
<dbReference type="PubMed" id="8168137"/>
<dbReference type="DOI" id="10.1016/0092-8674(94)90322-0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH PDGFRB</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Urinary bladder</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1996" name="Genome Res." volume="6" first="404" last="413">
<title>Genomic organization of TEL: the human ETS-variant gene 6.</title>
<authorList>
<person name="Baens M."/>
<person name="Peeters P."/>
<person name="Guo C."/>
<person name="Aerssens J."/>
<person name="Marynen P."/>
</authorList>
<dbReference type="PubMed" id="8743990"/>
<dbReference type="DOI" id="10.1101/gr.6.5.404"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 56-109; 111-336 AND 338-452</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2007" name="Nature" volume="446" first="758" last="764">
<title>Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.</title>
<authorList>
<person name="Mullighan C.G."/>
<person name="Goorha S."/>
<person name="Radtke I."/>
<person name="Miller C.B."/>
<person name="Coustan-Smith E."/>
<person name="Dalton J.D."/>
<person name="Girtman K."/>
<person name="Mathew S."/>
<person name="Ma J."/>
<person name="Pounds S.B."/>
<person name="Su X."/>
<person name="Pui C.-H."/>
<person name="Relling M.V."/>
<person name="Evans W.E."/>
<person name="Shurtleff S.A."/>
<person name="Downing J.R."/>
</authorList>
<dbReference type="PubMed" id="17344859"/>
<dbReference type="DOI" id="10.1038/nature05690"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 56-452</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH PAX5</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1995" name="Oncogene" volume="10" first="1511" last="1519">
<title>Translocation (12;22) (p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11.</title>
<authorList>
<person name="Buijs A."/>
<person name="Sherr S."/>
<person name="van Baal S."/>
<person name="van Bezouw S."/>
<person name="van der Plas D."/>
<person name="Geurts van Kessel A."/>
<person name="Riegman P."/>
<person name="Lekanne Deprez R."/>
<person name="Zwarthoff E."/>
<person name="Hagemeijer A."/>
</authorList>
<dbReference type="PubMed" id="7731705"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH MN1</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1995" name="Proc. Natl. Acad. Sci. U.S.A." volume="92" first="4917" last="4921">
<title>Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.</title>
<authorList>
<person name="Golub T.R."/>
<person name="Barker G.F."/>
<person name="Bohlander S.K."/>
<person name="Hiebert S.W."/>
<person name="Ward D.C."/>
<person name="Bray-Ward P."/>
<person name="Morgan E."/>
<person name="Raimondi S.C."/>
<person name="Rowley J.D."/>
<person name="Gilliland D.G."/>
</authorList>
<dbReference type="PubMed" id="7761424"/>
<dbReference type="DOI" id="10.1073/pnas.92.11.4917"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH AML1</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1995" name="Blood" volume="85" first="3662" last="3670">
<title>The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion.</title>
<authorList>
<person name="Romana S.P."/>
<person name="Mauchauffe M."/>
<person name="le Coniat M."/>
<person name="Chumakov I."/>
<person name="le Paslier D."/>
<person name="Berger R."/>
<person name="Bernard O.A."/>
</authorList>
<dbReference type="PubMed" id="7780150"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH AML1</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1997" name="Blood" volume="90" first="2535" last="2540">
<title>Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia.</title>
<authorList>
<person name="Peeters P."/>
<person name="Raynaud S.D."/>
<person name="Cools J."/>
<person name="Wlodarska I."/>
<person name="Grosgeorge J."/>
<person name="Philip P."/>
<person name="Monpoux F."/>
<person name="Van Rompaey L."/>
<person name="Baens M."/>
<person name="Van Den Berghe H."/>
<person name="Marynen P."/>
</authorList>
<dbReference type="PubMed" id="9326218"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATIONS WITH JAK2</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="Genes Chromosomes Cancer" volume="26" first="192" last="202">
<title>Fusion of TEL/ETV6 to a novel ACS2 in myelodysplastic syndrome and acute myelogenous leukemia with t(5;12)(q31;p13).</title>
<authorList>
<person name="Yagasaki F."/>
<person name="Jinnai I."/>
<person name="Yoshida S."/>
<person name="Yokoyama Y."/>
<person name="Matsuda A."/>
<person name="Kusumoto S."/>
<person name="Kobayashi H."/>
<person name="Terasaki H."/>
<person name="Ohyashiki K."/>
<person name="Asou N."/>
<person name="Murohashi I."/>
<person name="Bessho M."/>
<person name="Hirashima K."/>
</authorList>
<dbReference type="PubMed" id="10502316"/>
<dbReference type="DOI" id="10.1002/(sici)1098-2264(199911)26:3&lt;192::aid-gcc2&gt;3.0.co;2-e"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH ACSL6</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1999" name="Blood" volume="94" first="1820" last="1824">
<title>Fusion of a novel gene, BTL, to ETV6 in acute myeloid leukemias with a t(4;12)(q11-q12;p13).</title>
<authorList>
<person name="Cools J."/>
<person name="Bilhou-Nabera C."/>
<person name="Wlodarska I."/>
<person name="Cabrol C."/>
<person name="Talmant P."/>
<person name="Bernard P."/>
<person name="Hagemeijer A."/>
<person name="Marynen P."/>
</authorList>
<dbReference type="PubMed" id="10477709"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH CHIC2</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2002" name="Biochem. Biophys. Res. Commun." volume="299" first="116" last="125">
<title>Functional regulation of TEL by p38-induced phosphorylation.</title>
<authorList>
<person name="Arai H."/>
<person name="Maki K."/>
<person name="Waga K."/>
<person name="Sasaki K."/>
<person name="Nakamura Y."/>
<person name="Imai Y."/>
<person name="Kurokawa M."/>
<person name="Hirai H."/>
<person name="Mitani K."/>
</authorList>
<dbReference type="PubMed" id="12435397"/>
<dbReference type="DOI" id="10.1016/s0006-291x(02)02588-3"/>
</citation>
<scope>PHOSPHORYLATION AT SER-22 AND SER-257</scope>
<scope>MUTAGENESIS OF SER-213; SER-238 AND SER-257</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2002" name="Genes Chromosomes Cancer" volume="35" first="11" last="19">
<title>A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome.</title>
<authorList>
<person name="Odero M.D."/>
<person name="Vizmanos J.L."/>
<person name="Roman J.P."/>
<person name="Lahortiga I."/>
<person name="Panizo C."/>
<person name="Calasanz M.J."/>
<person name="Zeleznik-Le N.J."/>
<person name="Rowley J.D."/>
<person name="Novo F.J."/>
</authorList>
<dbReference type="PubMed" id="12203785"/>
<dbReference type="DOI" id="10.1002/gcc.10090"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH MDS2</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2002" name="N. Engl. J. Med." volume="347" first="481" last="487">
<title>Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta.</title>
<authorList>
<person name="Apperley J.F."/>
<person name="Gardembas M."/>
<person name="Melo J.V."/>
<person name="Russell-Jones R."/>
<person name="Bain B.J."/>
<person name="Baxter E.J."/>
<person name="Chase A."/>
<person name="Chessells J.M."/>
<person name="Colombat M."/>
<person name="Dearden C.E."/>
<person name="Dimitrijevic S."/>
<person name="Mahon F.-X."/>
<person name="Marin D."/>
<person name="Nikolova Z."/>
<person name="Olavarria E."/>
<person name="Silberman S."/>
<person name="Schultheis B."/>
<person name="Cross N.C.P."/>
<person name="Goldman J.M."/>
</authorList>
<dbReference type="PubMed" id="12181402"/>
<dbReference type="DOI" id="10.1056/nejmoa020150"/>
</citation>
<scope>INVOLVEMENT IN MPE</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH PDGFRB</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="15412" last="15420">
<title>The human L(3)MBT Polycomb group protein is a transcriptional repressor and interacts physically and functionally with TEL (ETV6).</title>
<authorList>
<person name="Boccuni P."/>
<person name="MacGrogan D."/>
<person name="Scandura J.M."/>
<person name="Nimer S.D."/>
</authorList>
<dbReference type="PubMed" id="12588862"/>
<dbReference type="DOI" id="10.1074/jbc.m300592200"/>
</citation>
<scope>INTERACTION WITH L3MBTL1</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="16059" last="16072">
<title>The histone deacetylase 9 gene encodes multiple protein isoforms.</title>
<authorList>
<person name="Petrie K."/>
<person name="Guidez F."/>
<person name="Howell L."/>
<person name="Healy L."/>
<person name="Waxman S."/>
<person name="Greaves M."/>
<person name="Zelent A."/>
</authorList>
<dbReference type="PubMed" id="12590135"/>
<dbReference type="DOI" id="10.1074/jbc.m212935200"/>
</citation>
<scope>INTERACTION WITH HDAC9</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="Oncogene" volume="24" first="4129" last="4137">
<title>Somatic heterozygous mutations in ETV6 (TEL) and frequent absence of ETV6 protein in acute myeloid leukemia.</title>
<authorList>
<person name="Barjesteh van Waalwijk van Doorn-Khosrovani S."/>
<person name="Spensberger D."/>
<person name="de Knegt Y."/>
<person name="Tang M."/>
<person name="Loewenberg B."/>
<person name="Delwel R."/>
</authorList>
<dbReference type="PubMed" id="15806161"/>
<dbReference type="DOI" id="10.1038/sj.onc.1208588"/>
</citation>
<scope>INVOLVEMENT IN AML</scope>
<scope>VARIANT GLY-344 INS</scope>
<scope>CHARACTERIZATION OF VARIANT GLY-344 INS</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-18 AND SER-22</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-11 AND LYS-302</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22 AND SER-213</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-11</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
<title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Treffers L.W."/>
<person name="Verlaan-de Vries M."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25772364"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-11</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-11 AND LYS-288</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2015" name="Nat. Genet." volume="47" first="180" last="185">
<title>Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy.</title>
<authorList>
<person name="Zhang M.Y."/>
<person name="Churpek J.E."/>
<person name="Keel S.B."/>
<person name="Walsh T."/>
<person name="Lee M.K."/>
<person name="Loeb K.R."/>
<person name="Gulsuner S."/>
<person name="Pritchard C.C."/>
<person name="Sanchez-Bonilla M."/>
<person name="Delrow J.J."/>
<person name="Basom R.S."/>
<person name="Forouhar M."/>
<person name="Gyurkocza B."/>
<person name="Schwartz B.S."/>
<person name="Neistadt B."/>
<person name="Marquez R."/>
<person name="Mariani C.J."/>
<person name="Coats S.A."/>
<person name="Hofmann I."/>
<person name="Lindsley R.C."/>
<person name="Williams D.A."/>
<person name="Abkowitz J.L."/>
<person name="Horwitz M.S."/>
<person name="King M.C."/>
<person name="Godley L.A."/>
<person name="Shimamura A."/>
</authorList>
<dbReference type="PubMed" id="25581430"/>
<dbReference type="DOI" id="10.1038/ng.3177"/>
</citation>
<scope>FUNCTION</scope>
<scope>INVOLVEMENT IN THC5</scope>
<scope>VARIANTS THC5 LEU-214; GLN-369 AND CYS-399</scope>
<scope>CHARACTERIZATION OF VARIANTS THC5 LEU-214; GLN-369 AND CYS-399</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-11; LYS-288; LYS-302; LYS-403 AND LYS-421</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="31">
<citation type="submission" date="2006-12" db="PDB data bank">
<title>Solution structure of ets domain transcriptional factor ETV6 protein.</title>
<authorList>
<consortium name="RIKEN structural genomics initiative (RSGI)"/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 338-442</scope>
</reference>
<comment type="function">
<text evidence="25">Transcriptional repressor; binds to the DNA sequence 5'-CCGGAAGT-3'. Plays a role in hematopoiesis and malignant transformation.</text>
</comment>
<comment type="subunit">
<text evidence="21 22">Can form homodimers or heterodimers with TEL2 or FLI1. Interacts with L3MBTL1 and HDAC9.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1372759">
<id>P41212</id>
</interactant>
<interactant intactId="EBI-541426">
<id>Q9BXS5</id>
<label>AP1M1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1372759">
<id>P41212</id>
</interactant>
<interactant intactId="EBI-16429430">
<id>A0A0S2Z4M1</id>
<label>AXIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1372759">
<id>P41212</id>
</interactant>
<interactant intactId="EBI-765476">
<id>Q9UKV0-3</id>
<label>HDAC9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1372759">
<id>P41212</id>
</interactant>
<interactant intactId="EBI-741158">
<id>Q96HA8</id>
<label>NTAQ1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1372759">
<id>P41212</id>
</interactant>
<interactant intactId="EBI-714158">
<id>Q13526</id>
<label>PIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text>Ubiquitous.</text>
</comment>
<comment type="PTM">
<text evidence="20">Phosphorylation of Ser-257 by MAPK14 (p38) inhibits ETV6 transcriptional repression.</text>
</comment>
<comment type="disease">
<text evidence="28">A chromosomal aberration involving ETV6 is found in a form of chronic myelomonocytic leukemia (CMML). Translocation t(5;12)(q33;p13) with PDGFRB. It is characterized by abnormal clonal myeloid proliferation and by progression to acute myelogenous leukemia (AML).</text>
</comment>
<comment type="disease">
<text evidence="16 26">Chromosomal aberrations involving ETV6 are found in acute myeloid leukemia (AML). Translocation t(12;22)(p13;q11) with MN1 (PubMed:7731705). Translocation t(4;12)(q12;p13) with CHIC2 (PubMed:10477709).</text>
</comment>
<comment type="disease">
<text evidence="27">Chromosomal aberrations involving ETV6 are found in childhood acute lymphoblastic leukemia (ALL). Translocations t(12;21)(p12;q22) and t(12;21)(p13;q22) with RUNX1/AML1.</text>
</comment>
<comment type="disease">
<text evidence="29">A chromosomal aberration involving ETV6 is found in a form of pre-B acute lymphoid leukemia. Translocation t(9;12)(p24;p13) with JAK2.</text>
</comment>
<comment type="disease">
<text evidence="29">A chromosomal aberration involving ETV6 and JAK2 is found in an atypical chronic myelogenous leukemia. Translocation t(9;15;12)(p24;q15;p13).</text>
</comment>
<comment type="disease">
<text evidence="17">A chromosomal aberration involving ETV6 is found in myelodysplastic syndrome (MDS) with basophilia. Translocation t(5;12)(q31;p13) with ACSL6.</text>
</comment>
<comment type="disease">
<text evidence="17">A chromosomal aberration involving ETV6 is found in acute eosinophilic leukemia (AEL). Translocation t(5;12)(q31;p13) with ACSL6.</text>
</comment>
<comment type="disease">
<text evidence="19">A chromosomal aberration involving ETV6 is found in myelodysplastic syndrome (MDS). Translocation t(1;12)(p36.1;p13) with MDS2.</text>
</comment>
<comment type="disease">
<text evidence="24">A chromosomal aberration involving ETV6 is found in acute lymphoblastic leukemia. Translocation t(9;12)(p13;p13) with PAX5.</text>
</comment>
<comment type="disease" evidence="18">
<disease id="DI-02609">
<name>Myeloproliferative disorder chronic with eosinophilia</name>
<acronym>MPE</acronym>
<description>A hematologic disorder characterized by malignant eosinophils proliferation.</description>
<dbReference type="MIM" id="131440"/>
</disease>
<text evidence="18">The gene represented in this entry is involved in disease pathogenesis. A chromosomal aberration involving ETV6 is found in many instances of myeloproliferative disorder chronic with eosinophilia. Translocation t(5;12) with PDGFRB on chromosome 5 creating an ETV6-PDGFRB fusion protein.</text>
</comment>
<comment type="disease" evidence="23">
<disease id="DI-01171">
<name>Leukemia, acute myelogenous</name>
<acronym>AML</acronym>
<description>A subtype of acute leukemia, a cancer of the white blood cells. AML is a malignant disease of bone marrow characterized by maturational arrest of hematopoietic precursors at an early stage of development. Clonal expansion of myeloid blasts occurs in bone marrow, blood, and other tissue. Myelogenous leukemias develop from changes in cells that normally produce neutrophils, basophils, eosinophils and monocytes.</description>
<dbReference type="MIM" id="601626"/>
</disease>
<text>The gene represented in this entry is involved in disease pathogenesis.</text>
</comment>
<comment type="disease" evidence="25">
<disease id="DI-04335">
<name>Thrombocytopenia 5</name>
<acronym>THC5</acronym>
<description>Thrombocytopenia is defined by a decrease in the number of platelets in circulating blood, resulting in the potential for increased bleeding and decreased ability for clotting. THC5 is an autosomal dominant disorder, associated with an increased susceptibility to the development of hematologic and solid malignancies.</description>
<dbReference type="MIM" id="616216"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="30">Belongs to the ETS family.</text>
</comment>
<comment type="sequence caution" evidence="30">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="ABI30005" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/ETV6ID38.html"/>
</comment>
<dbReference type="EMBL" id="U11732">
<property type="protein sequence ID" value="AAA19786.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK289441">
<property type="protein sequence ID" value="BAF82130.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471094">
<property type="protein sequence ID" value="EAW96240.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC043399">
<property type="protein sequence ID" value="AAH43399.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U61375">
<property type="protein sequence ID" value="AAC50690.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U63312">
<property type="protein sequence ID" value="AAB17134.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U63313">
<property type="protein sequence ID" value="AAB17135.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ841178">
<property type="protein sequence ID" value="ABI30005.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS8643.1"/>
<dbReference type="RefSeq" id="NP_001978.1">
<property type="nucleotide sequence ID" value="NM_001987.4"/>
</dbReference>
<dbReference type="PDB" id="1JI7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.45"/>
<property type="chains" value="A/B/C=47-123"/>
</dbReference>
<dbReference type="PDB" id="1LKY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B/C/D/E/F=47-123"/>
</dbReference>
<dbReference type="PDB" id="2DAO">
<property type="method" value="NMR"/>
<property type="chains" value="A=338-442"/>
</dbReference>
<dbReference type="PDB" id="2QAR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B/D/E=47-124"/>
</dbReference>
<dbReference type="PDB" id="2QB0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.56"/>
<property type="chains" value="A/C=47-123"/>
</dbReference>
<dbReference type="PDB" id="2QB1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.61"/>
<property type="chains" value="A/B=47-121"/>
</dbReference>
<dbReference type="PDB" id="5L0P">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=47-356"/>
</dbReference>
<dbReference type="PDBsum" id="1JI7"/>
<dbReference type="PDBsum" id="1LKY"/>
<dbReference type="PDBsum" id="2DAO"/>
<dbReference type="PDBsum" id="2QAR"/>
<dbReference type="PDBsum" id="2QB0"/>
<dbReference type="PDBsum" id="2QB1"/>
<dbReference type="PDBsum" id="5L0P"/>
<dbReference type="BMRB" id="P41212"/>
<dbReference type="SMR" id="P41212"/>
<dbReference type="BioGRID" id="108421">
<property type="interactions" value="45"/>
</dbReference>
<dbReference type="DIP" id="DIP-17028N"/>
<dbReference type="ELM" id="P41212"/>
<dbReference type="IntAct" id="P41212">
<property type="interactions" value="24"/>
</dbReference>
<dbReference type="MINT" id="P41212"/>
<dbReference type="STRING" id="9606.ENSP00000379658"/>
<dbReference type="BindingDB" id="P41212"/>
<dbReference type="ChEMBL" id="CHEMBL2401606"/>
<dbReference type="DrugCentral" id="P41212"/>
<dbReference type="iPTMnet" id="P41212"/>
<dbReference type="PhosphoSitePlus" id="P41212"/>
<dbReference type="BioMuta" id="ETV6"/>
<dbReference type="DMDM" id="730927"/>
<dbReference type="EPD" id="P41212"/>
<dbReference type="jPOST" id="P41212"/>
<dbReference type="MassIVE" id="P41212"/>
<dbReference type="MaxQB" id="P41212"/>
<dbReference type="PaxDb" id="P41212"/>
<dbReference type="PeptideAtlas" id="P41212"/>
<dbReference type="PRIDE" id="P41212"/>
<dbReference type="ProteomicsDB" id="55416"/>
<dbReference type="Antibodypedia" id="634">
<property type="antibodies" value="377 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="2120"/>
<dbReference type="Ensembl" id="ENST00000396373">
<property type="protein sequence ID" value="ENSP00000379658"/>
<property type="gene ID" value="ENSG00000139083"/>
</dbReference>
<dbReference type="GeneID" id="2120"/>
<dbReference type="KEGG" id="hsa:2120"/>
<dbReference type="UCSC" id="uc001qzz.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2120"/>
<dbReference type="DisGeNET" id="2120"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000139083.10"/>
<dbReference type="GeneCards" id="ETV6"/>
<dbReference type="HGNC" id="HGNC:3495">
<property type="gene designation" value="ETV6"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000139083">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="ETV6"/>
<dbReference type="MIM" id="131440">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="600618">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="601626">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="616216">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P41212"/>
<dbReference type="OpenTargets" id="ENSG00000139083"/>
<dbReference type="Orphanet" id="98823">
<property type="disease" value="Chronic myelomonocytic leukemia"/>
</dbReference>
<dbReference type="Orphanet" id="2665">
<property type="disease" value="Congenital mesoblastic nephroma"/>
</dbReference>
<dbReference type="Orphanet" id="146">
<property type="disease" value="Differentiated thyroid carcinoma"/>
</dbReference>
<dbReference type="Orphanet" id="71290">
<property type="disease" value="Familial platelet disorder with associated myeloid malignancy"/>
</dbReference>
<dbReference type="Orphanet" id="2030">
<property type="disease" value="Fibrosarcoma"/>
</dbReference>
<dbReference type="Orphanet" id="99860">
<property type="disease" value="Precursor B-cell acute lymphoblastic leukemia"/>
</dbReference>
<dbReference type="Orphanet" id="314950">
<property type="disease" value="Primary hypereosinophilic syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA27909"/>
<dbReference type="eggNOG" id="KOG3804">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000159508"/>
<dbReference type="HOGENOM" id="CLU_037998_1_0_1"/>
<dbReference type="InParanoid" id="P41212"/>
<dbReference type="KO" id="K03211"/>
<dbReference type="OMA" id="CIKQERI"/>
<dbReference type="OrthoDB" id="559763at2759"/>
<dbReference type="PhylomeDB" id="P41212"/>
<dbReference type="TreeFam" id="TF318679"/>
<dbReference type="PathwayCommons" id="P41212"/>
<dbReference type="Reactome" id="R-HSA-9673768">
<property type="pathway name" value="Signaling by membrane-tethered fusions of PDGFRA or PDGFRB"/>
</dbReference>
<dbReference type="SIGNOR" id="P41212"/>
<dbReference type="BioGRID-ORCS" id="2120">
<property type="hits" value="20 hits in 897 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="ETV6">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P41212"/>
<dbReference type="GeneWiki" id="ETV6"/>
<dbReference type="GenomeRNAi" id="2120"/>
<dbReference type="Pharos" id="P41212">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P41212"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 12"/>
</dbReference>
<dbReference type="RNAct" id="P41212">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000139083">
<property type="expression patterns" value="Expressed in mammary gland and 206 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P41212">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P41212">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0042025">
<property type="term" value="C:host cell nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0001227">
<property type="term" value="F:DNA-binding transcription repressor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0019904">
<property type="term" value="F:protein domain specific binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000977">
<property type="term" value="F:RNA polymerase II transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0071425">
<property type="term" value="P:hematopoietic stem cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097152">
<property type="term" value="P:mesenchymal cell apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0022008">
<property type="term" value="P:neurogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007296">
<property type="term" value="P:vitellogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.150.50">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000418">
<property type="entry name" value="Ets_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR003118">
<property type="entry name" value="Pointed_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR013761">
<property type="entry name" value="SAM/pointed_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR036388">
<property type="entry name" value="WH-like_DNA-bd_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR036390">
<property type="entry name" value="WH_DNA-bd_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF00178">
<property type="entry name" value="Ets"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02198">
<property type="entry name" value="SAM_PNT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00454">
<property type="entry name" value="ETSDOMAIN"/>
</dbReference>
<dbReference type="SMART" id="SM00413">
<property type="entry name" value="ETS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00251">
<property type="entry name" value="SAM_PNT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF46785">
<property type="entry name" value="SSF46785"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47769">
<property type="entry name" value="SSF47769"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00346">
<property type="entry name" value="ETS_DOMAIN_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50061">
<property type="entry name" value="ETS_DOMAIN_3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51433">
<property type="entry name" value="PNT"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Transcription factor ETV6" id="PRO_0000204121">
<location>
<begin position="1"/>
<end position="452"/>
</location>
</feature>
<feature type="domain" description="PNT" evidence="15">
<location>
<begin position="40"/>
<end position="124"/>
</location>
</feature>
<feature type="DNA-binding region" description="ETS" evidence="14">
<location>
<begin position="339"/>
<end position="420"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form CHIC2-ETV6 in AML">
<location>
<begin position="11"/>
<end position="12"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form ETV6-MDS2 in MDS">
<location>
<begin position="54"/>
<end position="55"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form PAX5-ETV6">
<location>
<begin position="55"/>
<end position="56"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form ETV6-AML1 in ALL">
<location>
<begin position="336"/>
<end position="337"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="5">
<location>
<position position="11"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6">
<location>
<position position="18"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 6 7 8 20">
<location>
<position position="22"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="213"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="238"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK14" evidence="20">
<location>
<position position="257"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="5">
<location>
<position position="302"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="323"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="9 10 11 12">
<location>
<position position="11"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="10 12">
<location>
<position position="288"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="12">
<location>
<position position="302"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="12">
<location>
<position position="403"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="12">
<location>
<position position="421"/>
</location>
</feature>
<feature type="sequence variant" description="In THC5; abrogates DNA binding; alters subcellular location; decreases transcriptional repression in a dominant-negative fashion; dbSNP:rs724159947." id="VAR_073322" evidence="25">
<original>P</original>
<variation>L</variation>
<location>
<position position="214"/>
</location>
</feature>
<feature type="sequence variant" description="In one individual with AML; somatic mutation; unable to repress transcription." id="VAR_034600" evidence="23">
<original>Y</original>
<variation>YG</variation>
<location>
<position position="344"/>
</location>
</feature>
<feature type="sequence variant" description="In THC5; abrogates DNA binding; alters subcellular location; decreases transcriptional repression in a dominant-negative fashion; dbSNP:rs724159946." id="VAR_073323" evidence="25">
<original>R</original>
<variation>Q</variation>
<location>
<position position="369"/>
</location>
</feature>
<feature type="sequence variant" description="In THC5; abrogates DNA binding; alters subcellular location; decreases transcriptional repression in a dominant-negative fashion; dbSNP:rs724159945." id="VAR_073324" evidence="25">
<original>R</original>
<variation>C</variation>
<location>
<position position="399"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect.">
<original>S</original>
<variation>A</variation>
<location>
<position position="22"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="20">
<original>S</original>
<variation>A</variation>
<location>
<position position="213"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="20">
<original>S</original>
<variation>A</variation>
<location>
<position position="238"/>
</location>
</feature>
<feature type="mutagenesis site" description="No phosphorylation by MAPK14." evidence="20">
<original>S</original>
<variation>A</variation>
<location>
<position position="257"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="12"/>
<end position="18"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="20"/>
<end position="22"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="23"/>
<end position="27"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="30"/>
<end position="38"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="52"/>
<end position="54"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="58"/>
<end position="60"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="63"/>
<end position="76"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="84"/>
<end position="87"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="91"/>
<end position="94"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="99"/>
<end position="105"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="107"/>
<end position="109"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="110"/>
<end position="122"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="341"/>
<end position="350"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="352"/>
<end position="354"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="355"/>
<end position="357"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="358"/>
<end position="362"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="363"/>
<end position="365"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="367"/>
<end position="371"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="373"/>
<end position="383"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="391"/>
<end position="403"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="406"/>
<end position="408"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="411"/>
<end position="419"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="424"/>
<end position="426"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="430"/>
<end position="432"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="434"/>
<end position="438"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1JI7"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2DAO"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5L0P"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25772364"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P97360"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00237"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00762"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10477709"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10502316"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12181402"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12203785"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12435397"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12588862"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12590135"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15806161"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344859"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25581430"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7731705"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7761424"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8168137"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9326218"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000305"/>
<sequence length="452" mass="53000" checksum="DEC45682ECADECBB" modified="1995-02-01" version="1">MSETPAQCSIKQERISYTPPESPVPSYASSTPLHVPVPRALRMEEDSIRLPAHLRLQPIYWSRDDVAQWLKWAENEFSLRPIDSNTFEMNGKALLLLTKEDFRYRSPHSGDVLYELLQHILKQRKPRILFSPFFHPGNSIHTQPEVILHQNHEEDNCVQRTPRPSVDNVHHNPPTIELLHRSRSPITTNHRPSPDPEQRPLRSPLDNMIRRLSPAERAQGPRPHQENNHQESYPLSVSPMENNHCPASSESHPKPSSPRQESTRVIQLMPSPIMHPLILNPRHSVDFKQSRLSEDGLHREGKPINLSHREDLAYMNHIMVSVSPPEEHAMPIGRIADCRLLWDYVYQLLSDSRYENFIRWEDKESKIFRIVDPNGLARLWGNHKNRTNMTYEKMSRALRHYYKLNIIRKEPGQRLLFRFMKTPDEIMSGRTDRLEHLESQELDEQIYQEDEC</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

